CD274 and non-small cell lung carcinoma: The comparative study on the efficacy of PD-L1 inhibitors and PD-1 inhibitors for local advanced NSCLC is limited, but the study of efficacy of immunotherapy for stage IV NSCLC showed similarity for PD-L1 inhibitors and PD-1 inhibitors (33–37).